Seroprevalence of Hepatitis B Virus Infection and Associated Factors among Cancer Patients at Hawassa University Comprehensive Specialized Hospital, Ethiopia
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.18479 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Surafel Nadew und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine and Health Science, Hawassa University, Hawassa, Ethiopia. Hauptthemen laut MEDLINE: Hepatitis B, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction
Hepatitis B virus infection is a global public health concern and has a high degree of associated morbidity and mortality. In Ethiopia, Hepatitis B virus infection has a variable seroprevalence among different regions with an estimated overall prevalence of around 6%. However, there is a scarcity of data specific to cancer patients. Methodology: A hospital-based cross-sectional study was conducted among 384 cancer patients who came for follow-up at the oncology unit of Hawassa University Comprehensive Specialized Hospital from January 1/2020 to October 11/2021. A systematic sampling technique was employed to select the participants. Data was collected using structured and interviewer-administered questionnaires and blood samples were drawn from the patients to test hepatitis B virus sero-status. Data was entered to Epi- Data version 4.6 then exported and analysis was done using SPSS version 25. Descriptive statistics were used to describe the study participants. Finally, bivariable and multivariable binary logistic regression was used to identify significantly associated factors.
Results
The seroprevalence of hepatitis B virus infection among cancer patients was 7.6% [95% CI: (4.54 - 9.79)]. Having multiple sexual partners (AOR = 6.24, 95% CI (3.35-16.80)), a history of dental procedures (AOR = 3.34; 95% CI (1.007‑7.66)), and being a hepatocellular carcinoma patient (AOR = 6.13; 95% CI (3.66-18.77)) were factors associated with seropositive status for Hepatitis B virus.
Conclusions
The seroprevalence of Hepatitis B virus infection among cancer patients was high. It is better to consider HBV screening in cancer patients and doing cancer surveillance in HBV-infected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, College of Medicine and Health Science, Hawassa University, Hawassa, Ethiopia.
- School of Medicine, College of Health Science, Woldia University, Woldia, Ethiopia.
- School of Public Health, College of Health Science, Woldia University, Woldia, Ethiopia.
- School of Nursing, College of Health Science, Woldia University, Woldia, Ethiopia.
Zitieren
APA
Nadew, S., Seyoum Wendimagegn, Z., Bizuneh, T., Bogale, N., Fenta Feleke, S., Mulu Yayeh, B., Birhanu Worku, A., Mulugeta Kassaw, G., Awoke, M., Nigatu, A., & Tesfa, N. A. (2024). Seroprevalence of Hepatitis B Virus Infection and Associated Factors among Cancer Patients at Hawassa University Comprehensive Specialized Hospital, Ethiopia. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.18479
Vancouver
Nadew S, Seyoum Wendimagegn Z, Bizuneh T, Bogale N, Fenta Feleke S, Mulu Yayeh B, et al. Seroprevalence of Hepatitis B Virus Infection and Associated Factors among Cancer Patients at Hawassa University Comprehensive Specialized Hospital, Ethiopia. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.18479
BibTeX
@article{Nadew2024,
author = {Nadew, Surafel and Seyoum Wendimagegn, Zeru and Bizuneh, Tinsae and Bogale, Netsanet and Fenta Feleke, Sefineh and Mulu Yayeh, Berihun and Birhanu Worku, Atsede and Mulugeta Kassaw, Genanew and Awoke, Mulat and Nigatu, Amare and Tesfa, Natnael Amare},
title = {Seroprevalence of Hepatitis B Virus Infection and Associated Factors among Cancer Patients at Hawassa University Comprehensive Specialized Hospital, Ethiopia},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.18479}
}
EUVIMED